p53 immunostaining is correlated with reduced survival and is not correlated with gene mutations in resected pulmonary large cell carcinomas.

about

p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors.Role of immunohistochemistry in the diagnosis of lung cancer.CD117, Ki-67, and p53 predict survival in neuroendocrine carcinomas, but not within the subgroup of small cell lung carcinoma.

P2860

Q35133362-957F74F7-88AF-4C0A-B19D-6F0C0AF6981F Q37494366-39796457-D77F-4B67-B475-FD1E0F35F7F3 Q54634445-7199341A-C46B-4ED5-B799-5E1CC98761D9

P2860

p53 immunostaining is correlated with reduced survival and is not correlated with gene mutations in resected pulmonary large cell carcinomas.

Item

http://www.wikidata.org/entity/Q53537207

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

p53 immunostaining is correlat ...... lmonary large cell carcinomas.

@en

p53 immunostaining is correlat ...... lmonary large cell carcinomas.

@nl

type

Item

label

p53 immunostaining is correlat ...... lmonary large cell carcinomas.

@en

p53 immunostaining is correlat ...... lmonary large cell carcinomas.

@nl

prefLabel

p53 immunostaining is correlat ...... lmonary large cell carcinomas.

@en

p53 immunostaining is correlat ...... lmonary large cell carcinomas.

@nl

P1476

p53 immunostaining is correlat ...... lmonary large cell carcinomas.

@en

P2093

A M Ab'Saber

http://www.w3.org/2001/XMLSchema#string

C P Bianchi

http://www.w3.org/2001/XMLSchema#string

E R Parra

http://www.w3.org/2001/XMLSchema#string

F A Soares

http://www.w3.org/2001/XMLSchema#string

J C Pereira

http://www.w3.org/2001/XMLSchema#string

K Leite

http://www.w3.org/2001/XMLSchema#string

L M Massoni Neto

http://www.w3.org/2001/XMLSchema#string

T Takagaki

http://www.w3.org/2001/XMLSchema#string

V L Capelozzi

http://www.w3.org/2001/XMLSchema#string

P2860

Large cell carcinoma of the lung with neuroendocrine differentiation. A comparison with large cell "undifferentiated" pulmonary tumors

Cancer. p53, guardian of the genome

Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology.

Large cell neuroendocrine carcinoma and large cell carcinomas with neuroendocrine morphology of the lung: prognosis after complete resection and systematic nodal dissection.

Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p

Genetic changes in the spectrum of neuroendocrine lung tumors.

The clinical significance of p53 aberrations in human tumours.

Clinical implications of the p53 tumor-suppressor gene.

Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung.

Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles.

P304

1045-1053

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/S0100-879X2006005000122

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17665040

http://www.w3.org/2001/XMLSchema#string

p53 immunostaining is correlated with reduced survival and is not correlated with gene mutations in resected pulmonary large cell carcinomas.

about

P2860

P2860

p53 immunostaining is correlated with reduced survival and is not correlated with gene mutations in resected pulmonary large cell carcinomas.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698